Webinar: A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis (ADAPT oculus)

Webinar: A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis (ADAPT oculus)

When

July 14, 2025    
3:00 pm

Monday, July 14, 2025 3:00 PM Eastern Time / 12:00 PM Pacific Time

Presenter:  Rosa H. Jimenz, M.D., PhD, MG Indication Lead, Clinical Development, argenx

Register